I remember quite a few posters on Ihub (I spent months over there and finally got tired of the antics of administrators) saying NP was ruining this company by diverting resources to covid... He should have just focused on HIV they said... I think he made the right choice and I think the FDA underestimated how much covid would mutate and overestimated BP role in providing effective treatments for it. They are really running out of excuses. Now the problem for BP and the FDA is once LL gets approval for one indication their are 50 more that should be approved as well...

LL is a game changer... The people that write the rules to the game don't like it